⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16703179 | 0.87 | — | — | |
| SCHEMBL126523 | 0.76 | — | — | |
| SCHEMBL3637558 | 0.59 | — | — | |
| SCHEMBL129122 | 0.59 | — | — | |
| SCHEMBL4175824 | 0.49 | — | — | |
| SCHEMBL958835 | 0.42 | — | — | |
| SCHEMBL34570 | 0.37 | — | — | |
| SCHEMBL3634636 | 0.37 | — | — | |
| SCHEMBL2326 | 0.37 | — | — | |
| SCHEMBL139589 | 0.37 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970541-A2 | SURFACE OXIDATION FOR SEQUESTERING BIOMOLECULES AND RELATED METHODS | NVS Technologies Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014152921-A2 | SURFACE OXIDATION FOR SEQUESTERING BIOMOLECULES AND RELATED METHODS | NVS Technologies, Inc. (US) | 2014-09-25 | — | — | WO | claimed |
| US-8623326-B2 | Ghrelin analogues | UNIVERSITY OF WESTERN ONTARIO (CA) | 2014-01-07 | — | — | US | claimed |
| EP-1327010-B1 | VAPOR DEPOSITION OF SILICATES | HARVARD COLLEGE (US) | 2013-12-04 | — | — | EP | claimed |
| US-11981703-B2 | Polynucleotide constructs | SIRIUS THERAPEUTICS, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| EP-4341241-A1 | CONTINUOUS FLOW PROCESS FOR PRODUCTION OF CATIONIC LIPIDS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2024-03-27 | — | — | EP | disclosed |
| US-11896965-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-02-13 | — | — | US | disclosed |
| WO-2023250427-A2 | FORMULATIONS FOR MODULATING MYC EXPRESSION | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023250429-A2 | COMBINATION THERAPIES COMPRISING MYC MODULATION | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230285556-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION | 2023-09-14 | — | — | US | disclosed |
| EP-4183770-A1 | CONTINUOUS FLOW PROCESS FOR PRODUCTION OF CATIONIC LIPIDS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-05-24 | — | — | EP | disclosed |
| US-20230112954-A1 | CHROMIUM COMPLEX AND CATALYST THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-04-13 | — | — | US | disclosed |
| US-6072054-A | Cyclic aryl ethers, thioethers, and amines and method preparation | UNIVERSITY OF WINNIPEG (CA) | 2000-06-06 | — | — | US | disclosed |
| WO-2000006566-A1 | BENZAZOLES: BENZOXAZOLE, BENZTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES | SYNGENTA LIMITED (GB) | 2000-02-10 | — | — | WO | disclosed |
| EP-0888268-A4 | METHOD FOR THE CYCLOTRIMERIZATION OF ALKYNES IN AQUEOUS SOLUTIONS | NEXSTAR PHARMACEUTICALS INC (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0888268-A1 | METHOD FOR THE CYCLOTRIMERIZATION OF ALKYNES IN AQUEOUS SOLUTIONS | NeXstar Pharmaceuticals, Inc. (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5760266-A | WATER SOLUBLE TRANSITION METAL CATALYST | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| WO-1997034857-A1 | METHOD FOR THE CYCLOTRIMERIZATION OF ALKYNES IN AQUEOUS SOLUTIONS | NEXSTAR PHARMACEUTICALS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| US-5659069-A | USING A WATER SOLUBLE TRANSITION METAL CATALYST | NEXSTAR PHARMACEUTICALS, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-4613670-A | MIGRATION FASTNESS, PERMANENCE | WRIGHT STATE UNIVERSITY (US) | 1986-09-23 | — | — | US | disclosed |